Christopher Murriel

Christopher Murriel is a Vice President at ArsenalBio, with years of experience in pharmacology, oncology, and pre-clinical studies. With a Ph.D. in Molecular Pharmacology from Stanford University, Christopher has held various senior positions in companies like Kinnate Biopharma Inc., Atreca, Inc., and more. Christopher's expertise includes providing scientific leadership, conducting in vivo pharmacology studies, and establishing collaborations within the industry and academia. Having also completed postdoctoral fellowships at University of California, San Diego and Genentech, Inc., Christopher's research focus has been on cancer development and cardio-protective effects in various models.